Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Shenling Baizhu granules (TCM patent medicine)
Universal Integrated
Low-risk Colorectal Adenoma
1 trial -
Taneasy 600mg granules
Biotech Pharmaceutical Co.,
COPD (Chronic Obstructive Pulmonary Disease)
1 trial -
Wangbi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
Wen Xin granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Yiqitongluo granule
The First People's Hospital of Lianyungang
Stroke
1 trial -
tong-jiang granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome
1 trial -
Fei Re Qing Granules
The First People's Hospital of Lianyungang
Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
1 trial -
Guben Kechuan Granules group
Universal Integrated
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Huang-long Zhi-xiao Granule
The First People's Hospital of Lianyungang
Asthma Chronic
1 trial -
Huangjing Yangji Formula Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcopenia
1 trial -
Ixekizumab+Jueyin Granules
Universal Integrated
Plaque Psoriasis
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Shenbai Granules
The First People's Hospital of Lianyungang
Colorectal Adenoma
1 trial -
Tianqi Pingchan Granule
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Levodopa-Induced Dyskinesia
1 trial -
Xiangsha Liujunzi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Functional Dyspepsia
1 trial -
Yin and Yang tonic granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteopenia
1 trial -
Yishen Qutong Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources